Financial Health Assessment: BAKRANS LIMITED

1. Financial Health Score: B-

Explanation: The patient exhibits signs of robust underlying vitality with an exceptionally strong immune system against insolvency (high liquidity, low debt). However, the recent sudden contraction in asset mass and the shedding of senior leadership (director resignations) are concerning symptoms. The score reflects a stable but currently contracting entity that requires monitoring to ensure the recent "weight loss" is intentional and not a symptom of a deeper underlying illness.

2. Key Vital Signs

• Pulse & Blood Pressure (Liquidity & Leverage): Strong and Stable. The company’s current assets (£15,215) vastly exceed its current liabilities (£2,670), yielding a current ratio of approximately 5.7:1. This indicates excellent short-term financial health—there is no risk of a "heart attack" from an inability to meet immediate obligations. Arteries are clear of dangerous debt blockages.
• Body Mass (Total Asset Size): Small Frame. With total assets of just £15,215, this is a micro-entity with a slight physical presence. It is a lean operational structure, typical for a property management vehicle.
• Weight Trajectory (Net Assets): Recent Sudden Loss. After a steady period of gaining "financial weight" (net assets grew from £8,283 in 2020 to £17,166 in 2024), the patient experienced a notable drop to £13,976 in 2025. This represents an 18.6% reduction in net worth over a single year.
• Temperature (Filing Compliance): Normal. Accounts are filed on time and are not overdue. The patient is attending its regular check-ups.
• Blood Composition (Director PSC): Unresolved Anomaly. The register for People with Significant Control (PSC) contains only a generic statement rather than named individuals, which is an irregularity in the corporate bloodwork that lacks full transparency.

3. Diagnosis

Mild Atrophy with Robust Underlying Health

The financial data reveals a business that is fundamentally healthy from a solvency perspective but is currently experiencing a contraction. The most prominent symptom is the sudden drop in both current assets and liabilities between 2024 and 2025. Total assets fell by £4,815 (from £20,030 to £15,215), while liabilities were reduced by £1,380 (from £4,050 to £2,670).

In a medical context, this looks like a patient who has suddenly lost weight and reduced their dietary intake. Because the company operates under the "Micro-entity" regime, we cannot see the Profit & Loss account (the patient has withheld details of their metabolic intake), so we cannot definitively say if this asset drop was caused by a trading loss or a deliberate distribution of funds (such as a dividend payout). However, given the reduction in liabilities alongside assets, this appears to be a deliberate "slimming down" rather than a forced asset sale due to distress.

A secondary symptom of note is the recent turnover in the boardroom. Two directors (Goodwin and Cleary) resigned in late 2025, while the registered office remains care of "Urang Property Management Limited." This suggests the company may be a special purpose vehicle (SPV) or a residents' management company transitioning its administrative management, which aligns with its SIC code (Management of real estate on a fee or contract basis).

4. Recommendations

1. Investigate the Weight Loss: Determine the cause of the £3,190 drop in net assets. If it was due to a trading loss, the underlying business model needs a health check. If it was a dividend distribution to shareholders, this is a healthy sign of a mature patient returning capital, but it leaves the company with a smaller financial cushion.
2. Vaccinate Against Inactivity: With such a high cash ratio and low liabilities, the company may be holding excessive idle assets. Ensure that capital is being put to productive use rather than sitting stagnant, which can erode value over time due to inflation.
3. Resolve PSC Transparency: The absence of a named Person with Significant Control is a regulatory deficiency. The company should update its statutory books to identify the ultimate beneficial owners, ensuring full corporate transparency and avoiding compliance penalties.
4. Monitor the New Board: With recent director resignations, ensure the remaining directors (Barnard and Gough) have full oversight of the company's operations and that the corporate secretary (Urang Property Management) is effectively administering the patient's ongoing care.